Treace Medical Concepts Q4 EPS $(0.15), Inline, Sales $62.519M Beat $61.390M Estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 1400 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $62.519 million which beat the analyst consensus estimate of $61.390 million by 1.84 percent. This is a 9.01 percent decrease over sales of $68.708 million the same period last year.